Specific KRAS-Mutant Cancers Are Sensitive to Inhibition of V-type ATPases.

doi:10.1158/2159-8290.CD-RW2022-142

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Specific KRAS-Mutant Cancers Are Sensitive to Inhibition of V-type ATPases.

Cancer discovery - 5 Oct 2022

Abstract excerpt

249C was identified as a selective Ras-mutant cytotoxic agent that binds to and inhibits V-ATPase.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cytotoxins
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins p21(ras)

Share to Vacuolar Proton-Translocating ATPases

Source

Open in PubMed

Identifiers

PMID: 35929746
DOI: 10.1158/2159-8290.CD-RW2022-142

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Specific KRAS-Mutant Cancers Are Sensitive to Inhibition of V-type ATPases.PMID 35929746Read ↗

Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice.Semantic proximity Read ↗

Selective Targeting of Ras Mutant Cancers via a New Small MoleculeSemantic proximity Read ↗

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell deathSemantic proximity Read ↗

The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinomaSemantic proximity Read ↗

V-ATPase Inhibition Decreases Mutant Androgen Receptor Activity in Castrate-resistant Prostate CancerSemantic proximity Read ↗

A H-REV107 Peptide Inhibits Tumor Growth and Interacts Directly with Oncogenic KRAS MutantsSemantic proximity Read ↗

V-ATPase Proton Pump May Take Part to Drug-Resistance Phenotype of Glioma Stem CellsSemantic proximity Read ↗

[Preclinical study of T cell receptor specifically reactive with KRAS G12V mutation in the treatment of malignant tumors].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.